With more than 39,000 members, the American Academy of Orthopaedic Surgeons (AAOS) is the world’s largest association of musculoskeletal specialists. The AAOS provides education programs for orthopaedic surgeons and allied health professionals, champions and advances the highest musculoskeletal care for patients, and is the authoritative source of information on bone and joint conditions, treatments, and related issues. Visit aaos.org for more information about the Academy; ANationinMotion.org for inspirational patient stories, and orthopaedic surgeon tips on maintaining bone and joint health, avoiding injuries, treating musculoskeletal conditions and navigating recovery; and Orthoinfo.org for patient information on hundreds of orthopaedic diseases and conditions.
Founded more than 40 years ago, Genentech is a leading biotechnology company that discovers, develops, manufactures and commercializes medicines to treat patients with serious or life-threatening medical conditions. Genentech has an extensive track record in all phases of bringing new disease treatments to patients from discovery research through clinical development, manufacturing, and commercialization. With multiple protein-based products on the market for serious or life-threatening medical conditions, Genentech has experience taking a drug from A to Z, transforming the seed of an idea in a lab into a novel therapy for a patient in need. The company, a member of the Roche Group, has headquarters in South San Francisco, California.
Sanofi Genzyme - Regeneron
The Sanofi Genzyme and Regeneron collaboration is committed to translating cutting-edge science into groundbreaking medicines for patients with serious needs. Regeneron is a leading science-based biopharmaceutical company that discovers, invents, develops, manufactures, and commercializes medicines for the treatment of serious medical conditions. Sanofi Genzyme, the specialty care business unit of Sanofi, focuses on rare diseases, multiple sclerosis, oncology, and immunology. Since 2007, Regeneron and Sanofi have collaborated to discover, develop, manufacture and commercialize fully human monoclonal antibodies.